These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6091696)

  • 21. Characterization of the sequence next to the 3-terminal poly-(A) of encephalomyocarditis virus RNA [proceedings].
    Merregaert J; Van Emmelo J; Devos R; Porter A; Gillis E; Fiers W
    Arch Int Physiol Biochim; 1977 Feb; 85(1):188-9. PubMed ID: 68742
    [No Abstract]   [Full Text] [Related]  

  • 22. Virus-induced diabetes mellitus. XXV. Difference in the RNA fingerprints of diabetogenic and non-diabetogenic variants of encephalomyocarditis virus.
    Ray UR; Aulakh GS; Schubert M; McClintock PR; Yoon JW; Notkins AL
    J Gen Virol; 1983 Apr; 64 (Pt 4)():947-50. PubMed ID: 6300311
    [No Abstract]   [Full Text] [Related]  

  • 23. An apparent deletion of an oligonucleotide detected by RNA fingerprint in the nondiabetogenic B variant of encephalomyocarditis virus is caused by a point mutation.
    Yoon JW; Wong AK; Bae YS; Eun HM
    J Virol; 1988 Feb; 62(2):637-40. PubMed ID: 2826821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The characteristics of synonymous codon usage in the initial and terminal translation regions of encephalomyocarditis virus.
    Ma XX; Feng YP; Liu JL; Zhao YQ; Chen L; Guo PH; Guo JZ; Ma ZR
    Acta Virol; 2014; 58(1):86-91. PubMed ID: 24720745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction and characterization of two infectious molecular clones of encephalomyocarditis virus.
    Naviaux RK; Cohen SH; Vanden Brink KM; Jordan GW
    J Virol; 1990 Feb; 64(2):913-7. PubMed ID: 2153252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic and receptor attachment differences between mengovirus and encephalomyocarditis virus.
    Morishima T; McClintock PR; Aulakh GS; Billups LC; Notkins AL
    Virology; 1982 Oct; 122(2):461-5. PubMed ID: 6293181
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparative studies on the genomes of some picornaviruses: denaturation mapping of replicative form RNA and electron microscopy of heteroduplex RNA.
    Cumakov IM; Lipskaya GY; Agol VI
    Virology; 1979 Jan; 92(2):259-70. PubMed ID: 218342
    [No Abstract]   [Full Text] [Related]  

  • 28. Conservation of the secondary structure elements of the 5'-untranslated region of cardio- and aphthovirus RNAs.
    Pilipenko EV; Blinov VM; Chernov BK; Dmitrieva TM; Agol VI
    Nucleic Acids Res; 1989 Jul; 17(14):5701-11. PubMed ID: 2548167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequence of 129 nucleotides at the 3'-terminus of encephalomyocarditis virus RNA.
    Porter AG; Merregaert J; Van Emmelo J; Fiers W
    Eur J Biochem; 1978 Jul; 87(3):551-61. PubMed ID: 79485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Localization of the polycytidylic sequence in the virion RNA molecule of the encephalomyocarditis virus].
    Chumakov KM; Agol VI
    Dokl Akad Nauk SSSR; 1976; 228(4):988-91. PubMed ID: 181231
    [No Abstract]   [Full Text] [Related]  

  • 31. The size and location of the poly(A) tract in EMC virus RNA.
    Burness AT; Pardoe IU; Duffy EM; Bhalla RB; Goldstein NO
    J Gen Virol; 1977 Feb; 34(2):331-44. PubMed ID: 190347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of encephalomyocarditis virus RNA polymerase to the 3'-noncoding region of the viral RNA is specific and requires the 3'-poly(A) tail.
    Cui T; Sankar S; Porter AG
    J Biol Chem; 1993 Dec; 268(35):26093-8. PubMed ID: 8253725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved dicistronic mRNA expression vectors for efficient selection of transfectants highly expressing foreign genes.
    Kobayashi M; Yamauchi Y; Tanaka A; Shimamura S
    Biotechniques; 1996 Sep; 21(3):398-402. PubMed ID: 8879573
    [No Abstract]   [Full Text] [Related]  

  • 34. Identification of the polyprotein termination site on encephalomyocarditis viral RNA.
    Drake NL; Palmenberg AC; Ghosh A; Omilianowski DR; Kaesberg P
    J Virol; 1982 Feb; 41(2):726-9. PubMed ID: 6281483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leader polypeptides encoded in the 5'-region of the encephalomyocarditis virus genome.
    Kazachkov YuA ; Chernovskaya TV; Siyanova EYu ; Svitkin YuV ; Ugarova TYu ; Agol VI
    FEBS Lett; 1982 May; 141(2):153-6. PubMed ID: 6284551
    [No Abstract]   [Full Text] [Related]  

  • 36. [Covalent bond between RNA and protein in encephalomyocarditis virus].
    Drygin IuF; Vartapetian AB; Chumakov KM
    Mol Biol (Mosk); 1979; 13(4):777-87. PubMed ID: 224308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absence of 5' terminal capping in encephalomyocarditis virus RNA.
    Frisby D; Eaton M; Fellner P
    Nucleic Acids Res; 1976 Oct; 3(10):2771-87. PubMed ID: 186763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Encephalomyocarditis virus can bind to and transfect non-permissive cells.
    Donta ST; Shanley JD; Damiano-Burbach P
    Arch Virol; 1986; 88(3-4):301-7. PubMed ID: 3010910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virulence and immunogenicity in mice of airborne encephalomyocarditis viruses and their infectious nucleic acids.
    Akers TG; Bond SB; Papke C; Leif WR
    J Immunol; 1966 Sep; 97(3):379-85. PubMed ID: 4288720
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of the nucleotide sequences of diabetogenic and nondiabetogenic encephalomyocarditis virus.
    Cohen SH; Naviaux RK; vanden Brink KM; Jordan GW
    Virology; 1988 Oct; 166(2):603-7. PubMed ID: 2845665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.